Paxton V Dickson
Overview
Explore the profile of Paxton V Dickson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
1316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Fleming A, Hendrick L, Glazer E, Murphy A, Dickson P, Shibata D, et al.
Surgery
. 2023 Jul;
174(4):907-915.
PMID: 37524640
Background: Pancreatic carcinosarcoma is a rare subtype of pancreatic cancer. There are no consensus guidelines regarding its treatment. The current study is an orthogonal analysis of multiple datasets to evaluate...
12.
Fleming A, Phillips A, Hendrick L, Drake J, Dickson P, Glazer E, et al.
HPB (Oxford)
. 2023 Jul;
25(11):1288-1299.
PMID: 37423850
Introduction: Data regarding oncologic outcomes of segmental bile duct resection (SBDR) versus pancreatoduodenectomy (PD) for bile duct cancers (BDC) are conflicting. We compared SBDR and PD for BDC utilizing pooled...
13.
Fleming A, Deschner B, Williard F, Drake J, VanderWalde A, Xiu J, et al.
J Surg Oncol
. 2023 Jan;
127(5):815-822.
PMID: 36629137
Background And Objectives: Published data comparing peritoneal metastases from appendiceal cancers (pAC) and colorectal cancers (pCRC) remain sparse. We compared pAC and pCRC using comprehensive tumor profiling (CTP). Methods: CTP...
14.
Impact of Social Determinants of Health on Outcomes Following Resection for Hepatocellular Carcinoma
Moten A, Dickson P, Deneve J, Shibata D, Stanfill A, Glazer E
Ann Surg Oncol
. 2022 Nov;
30(2):738-747.
PMID: 36319871
Background: We sought to determine the impact of social determinants of health (SDoH) on outcomes of patients undergoing resection for hepatocellular carcinoma (HCC). Patients And Methods: Patients with HCC in...
15.
Stiles Z, Fleming A, Dickson P, Tsao M, Glazer E, Shibata D, et al.
Ann Surg Oncol
. 2022 Oct;
29(13):8641-8648.
PMID: 36197560
Background: Lymph node (LN) metastases are uncommon among gastrointestinal stromal tumors (GISTs), and their presence has not been utilized in disease prognostication. This study was designed to examine factors associated...
16.
Drake J, Fleming A, Behrman S, Glazer E, Deneve J, Yakoub D, et al.
J Gastrointest Surg
. 2022 Jun;
26(10):2136-2147.
PMID: 35768717
Background: Chemotherapy (CTX) is associated with improved survival for patients undergoing resection for pancreatic ductal adenocarcinoma (PDAC). The current study evaluated the influence of tumor location on receipt of CTX....
17.
Tsao M, Kahl M, Deneve J, Yakoub D, Glazer E, Shibata D, et al.
Am Surg
. 2022 May;
88(9):2280-2288.
PMID: 35570820
Background: National studies have reported racial and socioeconomic disparities in gastric cancer (GC) care. The current study evaluated adequate lymph node (LN) assessment (≥16 LNs) during resection for GC within...
18.
Hendrick L, Zambetti B, Wong D, Dickson P, Glazer E, Shibata D, et al.
J Surg Oncol
. 2022 Mar;
125(8):1231-1237.
PMID: 35234280
Background And Objectives: Visceral angiosarcoma is rare and aggressive, accounting for 2% of soft tissue sarcomas. Using a national data set, we examine determinants of outcomes for patients presenting with...
19.
Hendrick L, Huang X, Hewgley W, Douthitt L, Dickson P, Glazer E, et al.
Am Surg
. 2022 Jan;
88(5):887-893.
PMID: 35012359
Background: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is associated with significant operative time, hospital resources, and morbidity. We examine factors associated with hospital length of stay (LOS) and early...
20.
Shah M, Goldner W, Benson A, Bergsland E, Blaszkowsky L, Brock P, et al.
J Natl Compr Canc Netw
. 2021 Aug;
19(7):839-868.
PMID: 34340212
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients with neuroendocrine tumors (NETs), adrenal tumors,...